"Mounjaro Face": What It Is, Why It Happens and What the Evidence Says

"Mounjaro face" and "Ozempic face" are popular terms, not medical ones. They describe changes in the face, such as hollowing or looser skin, that some people notice while losing weight on medicines such as Mounjaro or Wegovy. This guide explains what the research shows about why it happens and what is and is not known about it.

What Is "Mounjaro Face"?

A popular term for facial hollowing, looser skin and folds during weight loss on GLP-1 medicines.

The term is used for changes some people notice in their face while losing weight on GLP-1 medicines, such as:

• hollowing, especially of the cheeks and midface;

• looser or less firm skin;

• more noticeable folds and lines.

It is not a recognised medical condition, and the UK product information for Mounjaro does not list facial changes among its side effects.

Is It Caused by the Medicine or by Weight Loss?

The evidence favours weight-loss-associated fat loss in the face, not a drug-specific effect.

A 2026 review in the Aesthetic Surgery Journal, which looked at 46 published reports, concluded that the term "Ozempic face" can imply a drug-specific side effect, "although similar changes occur after other forms of substantial weight loss". It found that current evidence favours weight-loss-associated deflation, on top of a person's existing facial anatomy and ageing.

In other words, the face loses fat along with the rest of the body. The Mounjaro product information says the weight lost on tirzepatide is mostly fat mass. Similar changes have been described after weight-loss surgery.

What the Research Shows

A median 9% midface volume loss in 20 patients, about 7% per 10 kg of weight lost.

The same review reported that:

• In imaging of 20 patients, midfacial volume fell by a median of 9%, with more loss in the fat layers just under the skin than in deeper ones.

• Loss was estimated at about 7% of midfacial volume for every 10 kg of body weight lost.

• In a survey of 1,226 people, facial volume loss and laxity were reported more often by those who had lost a larger percentage of their weight.

• Studies after weight-loss surgery describe facial deflation and looking older, particularly in older people and after larger losses.

These are small or early studies, and the review notes several open questions.

Who Is More Likely to Notice It?

People who lose more weight and older people; the role of speed of loss is uncertain.

The research points to two factors: how much weight is lost and age. Larger losses were linked to more reported facial change, and studies after surgery found more noticeable effects in older people.

Other factors are less clear. The review says the independent effect of how fast weight is lost, and the roles of menopause and hormone therapy, remain uncertain.

Can It Be Prevented?

No proven prevention; take your medicine as prescribed and talk to your prescriber.

There is no proven way to prevent it. The review describes the evidence on treatments as limited and largely uncontrolled.

What is within your control is taking your medicine as prescribed. The MHRA advises against trying to "fast-track" weight loss by increasing your dose, and the dose of Mounjaro is meant to be increased in steps, at least 4 weeks apart. See Mounjaro dosage. If you are worried about changes in your face, talk to your prescriber.

Other Changes in Appearance

Hair loss is a recognised side effect, usually mild and recovering.

Some other appearance changes are recognised side effects:

• Hair loss was reported by 4.9% of people on tirzepatide and 1.0% on placebo in the weight management trials. It was mainly mild, and most people recovered while still taking it.

See Mounjaro side effects for the full list, and report suspected side effects to the MHRA Yellow Card scheme.

If You Are Considering Cosmetic Treatment

Evidence is limited; choose a qualified, regulated practitioner and take your time.

Because the evidence on treatments for these changes is limited, take time over any decision. Choose a qualified, regulated practitioner, ask what evidence supports a treatment, and tell them you take Mounjaro.

If changes in your appearance are affecting your mood or wellbeing, speak to your GP or prescriber.

Frequently Asked Questions